• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Structural and mechanistic insights into Hsp104 function revealed by synchrotron X-ray footprinting.利用同步辐射 X 射线足迹法揭示 Hsp104 功能的结构和机制见解。
J Biol Chem. 2020 Feb 7;295(6):1517-1538. doi: 10.1074/jbc.RA119.011577. Epub 2019 Dec 27.
2
Mechanistic Insights into Hsp104 Potentiation.Hsp104增强作用的机制性见解。
J Biol Chem. 2016 Mar 4;291(10):5101-15. doi: 10.1074/jbc.M115.707976. Epub 2016 Jan 8.
3
Mining Disaggregase Sequence Space to Safely Counter TDP-43, FUS, and α-Synuclein Proteotoxicity.挖掘去组装酶序列空间以安全应对 TDP-43、FUS 和 α-突触核蛋白毒性。
Cell Rep. 2019 Aug 20;28(8):2080-2095.e6. doi: 10.1016/j.celrep.2019.07.069.
4
Mechanistic and Structural Insights into the Prion-Disaggregase Activity of Hsp104.Hsp104朊病毒解聚酶活性的机制与结构见解
J Mol Biol. 2016 May 8;428(9 Pt B):1870-85. doi: 10.1016/j.jmb.2015.11.016. Epub 2015 Dec 1.
5
The Hsp104 N-terminal domain enables disaggregase plasticity and potentiation.热休克蛋白104(Hsp104)的N端结构域赋予解聚酶可塑性和增强作用。
Mol Cell. 2015 Mar 5;57(5):836-849. doi: 10.1016/j.molcel.2014.12.021. Epub 2015 Jan 22.
6
Conserved distal loop residues in the Hsp104 and ClpB middle domain contact nucleotide-binding domain 2 and enable Hsp70-dependent protein disaggregation.Hsp104和ClpB中间结构域中保守的远端环残基与核苷酸结合结构域2接触,并实现Hsp70依赖的蛋白质解聚。
J Biol Chem. 2014 Jan 10;289(2):848-67. doi: 10.1074/jbc.M113.520759. Epub 2013 Nov 26.
7
Structural determinants for protein unfolding and translocation by the Hsp104 protein disaggregase.Hsp104 蛋白解折叠酶使蛋白质展开和易位的结构决定因素。
Biosci Rep. 2017 Dec 22;37(6). doi: 10.1042/BSR20171399.
8
Spiraling in Control: Structures and Mechanisms of the Hsp104 Disaggregase.螺旋控制:Hsp104 解聚酶的结构和机制。
Cold Spring Harb Perspect Biol. 2019 Aug 1;11(8):a034033. doi: 10.1101/cshperspect.a034033.
9
Motor mechanism for protein threading through Hsp104.蛋白质穿过Hsp104的运动机制
Mol Cell. 2009 Apr 10;34(1):81-92. doi: 10.1016/j.molcel.2009.02.026.
10
Evidence for an unfolding/threading mechanism for protein disaggregation by Saccharomyces cerevisiae Hsp104.酿酒酵母Hsp104介导蛋白质解聚的解折叠/穿线机制的证据。
J Biol Chem. 2004 Jul 9;279(28):29139-46. doi: 10.1074/jbc.M403777200. Epub 2004 May 5.

引用本文的文献

1
Mapping Hsp104 interactions using cross-linking mass spectrometry.利用交联质谱法绘制Hsp104相互作用图谱。
FEBS Open Bio. 2025 Jun;15(6):922-939. doi: 10.1002/2211-5463.70007. Epub 2025 Feb 24.
2
Design principles to tailor Hsp104 therapeutics.定制Hsp104疗法的设计原则。
Cell Rep. 2024 Dec 24;43(12):115005. doi: 10.1016/j.celrep.2024.115005. Epub 2024 Dec 12.
3
Design principles to tailor Hsp104 therapeutics.定制Hsp104疗法的设计原则。
bioRxiv. 2024 Apr 28:2024.04.26.591398. doi: 10.1101/2024.04.26.591398.
4
Hsp104 N-terminal domain interaction with substrates plays a regulatory role in protein disaggregation.Hsp104 N 端结构域与底物的相互作用在蛋白质解聚中起调节作用。
FEBS J. 2022 Sep;289(17):5359-5377. doi: 10.1111/febs.16441. Epub 2022 Mar 30.
5
Heat Stress Tolerance Gene Affects Conidiation and Pathogenicity of .热胁迫耐受性基因影响……的分生孢子形成和致病性。 (注:原文中“of”后面缺少具体内容)
Front Microbiol. 2021 Jul 28;12:695535. doi: 10.3389/fmicb.2021.695535. eCollection 2021.
6
Drivers of Hsp104 potentiation revealed by scanning mutagenesis of the middle domain.扫描诱变中间结构域揭示 Hsp104 增强的驱动因素。
Protein Sci. 2021 Aug;30(8):1667-1685. doi: 10.1002/pro.4126. Epub 2021 Jun 1.
7
Entropic Inhibition: How the Activity of a AAA+ Machine Is Modulated by Its Substrate-Binding Domain.熵抑制:AAA+ 机器的活性如何被其底物结合域调节。
ACS Chem Biol. 2021 Apr 16;16(4):775-785. doi: 10.1021/acschembio.1c00156. Epub 2021 Mar 19.
8
Therapeutic genetic variation revealed in diverse Hsp104 homologs.在不同的 Hsp104 同源物中发现了治疗性遗传变异。
Elife. 2020 Dec 15;9:e57457. doi: 10.7554/eLife.57457.
9
Skd3 (human ClpB) is a potent mitochondrial protein disaggregase that is inactivated by 3-methylglutaconic aciduria-linked mutations.Skd3(人源 ClpB)是一种有效的线粒体蛋白解聚酶,其活性会被与 3-甲基戊烯二酸血症相关的突变所抑制。
Elife. 2020 Jun 23;9:e55279. doi: 10.7554/eLife.55279.

本文引用的文献

1
Mining Disaggregase Sequence Space to Safely Counter TDP-43, FUS, and α-Synuclein Proteotoxicity.挖掘去组装酶序列空间以安全应对 TDP-43、FUS 和 α-突触核蛋白毒性。
Cell Rep. 2019 Aug 20;28(8):2080-2095.e6. doi: 10.1016/j.celrep.2019.07.069.
2
Hsp104 and Potentiated Variants Can Operate as Distinct Nonprocessive Translocases.Hsp104 和增强变体可作为不同的非进展性移位酶发挥作用。
Biophys J. 2019 May 21;116(10):1856-1872. doi: 10.1016/j.bpj.2019.03.035. Epub 2019 Apr 5.
3
AAA+ Protein-Based Technologies to Counter Neurodegenerative Disease.AAA+ 蛋白基技术对抗神经退行性疾病。
Biophys J. 2019 Apr 23;116(8):1380-1385. doi: 10.1016/j.bpj.2019.03.007. Epub 2019 Mar 22.
4
Hydrogen exchange reveals Hsp104 architecture, structural dynamics, and energetics in physiological solution.氢交换揭示了生理溶液中 Hsp104 的结构、结构动力学和能量学。
Proc Natl Acad Sci U S A. 2019 Apr 9;116(15):7333-7342. doi: 10.1073/pnas.1816184116. Epub 2019 Mar 27.
5
Spiraling in Control: Structures and Mechanisms of the Hsp104 Disaggregase.螺旋控制:Hsp104 解聚酶的结构和机制。
Cold Spring Harb Perspect Biol. 2019 Aug 1;11(8):a034033. doi: 10.1101/cshperspect.a034033.
6
Therapeutic Dissolution of Aberrant Phases by Nuclear-Import Receptors.核输入受体对异常相位的治疗性溶解。
Trends Cell Biol. 2019 Apr;29(4):308-322. doi: 10.1016/j.tcb.2018.12.004. Epub 2019 Jan 16.
7
Structure of Calcarisporiella thermophila Hsp104 Disaggregase that Antagonizes Diverse Proteotoxic Misfolding Events.嗜热石座菌 Hsp104 解聚酶的结构,该酶能拮抗多种蛋白毒性错误折叠事件。
Structure. 2019 Mar 5;27(3):449-463.e7. doi: 10.1016/j.str.2018.11.001. Epub 2018 Dec 27.
8
Development of Synchrotron Footprinting at NSLS and NSLS-II.NSLS和NSLS-II同步辐射足迹技术的发展。
Protein Pept Lett. 2019;26(1):55-60. doi: 10.2174/0929866526666181128125125.
9
Different Material States of Pub1 Condensates Define Distinct Modes of Stress Adaptation and Recovery.Pub1 凝聚物的不同物质状态定义了不同的应激适应和恢复模式。
Cell Rep. 2018 Jun 12;23(11):3327-3339. doi: 10.1016/j.celrep.2018.05.041.
10
Potentiating Hsp104 activity via phosphomimetic mutations in the middle domain.通过在中间结构域中进行磷酸模拟突变来增强 Hsp104 活性。
FEMS Yeast Res. 2018 Aug 1;18(5). doi: 10.1093/femsyr/foy042.

利用同步辐射 X 射线足迹法揭示 Hsp104 功能的结构和机制见解。

Structural and mechanistic insights into Hsp104 function revealed by synchrotron X-ray footprinting.

机构信息

Department of Biochemistry and Biophysics, University of Pennsylvania, Philadelphia, Pennsylvania 19104; Biochemistry and Molecular Biophysics Graduate Group, University of Pennsylvania, Philadelphia, Pennsylvania 19104.

Department of Biochemistry and Biophysics, University of Pennsylvania, Philadelphia, Pennsylvania 19104.

出版信息

J Biol Chem. 2020 Feb 7;295(6):1517-1538. doi: 10.1074/jbc.RA119.011577. Epub 2019 Dec 27.

DOI:10.1074/jbc.RA119.011577
PMID:31882541
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7008382/
Abstract

Hsp104 is a hexameric AAA ring translocase, which drives protein disaggregation in nonmetazoan eukaryotes. Cryo-EM structures of Hsp104 have suggested potential mechanisms of substrate translocation, but precisely how Hsp104 hexamers disaggregate proteins remains incompletely understood. Here, we employed synchrotron X-ray footprinting to probe the solution-state structures of Hsp104 monomers in the absence of nucleotide and Hsp104 hexamers in the presence of ADP or ATPγS (adenosine 5'--(thiotriphosphate)). Comparing side-chain solvent accessibilities between these three states illuminated aspects of Hsp104 structure and guided design of Hsp104 variants to probe the disaggregase mechanism and We established that Hsp104 hexamers switch from a more-solvated state in ADP to a less-solvated state in ATPγS, consistent with switching from an open spiral to a closed ring visualized by cryo-EM. We pinpointed critical N-terminal domain (NTD), NTD-nucleotide-binding domain 1 (NBD1) linker, NBD1, and middle domain (MD) residues that enable intrinsic disaggregase activity and Hsp70 collaboration. We uncovered NTD residues in the loop between helices A1 and A2 that can be substituted to enhance disaggregase activity. We elucidated a novel potentiated Hsp104 MD variant, Hsp104-RYD, which suppresses α-synuclein, fused in sarcoma (FUS), and TDP-43 toxicity. We disambiguated a secondary pore-loop in NBD1, which collaborates with the NTD and NBD1 tyrosine-bearing pore-loop to drive protein disaggregation. Finally, we defined Leu-601 in NBD2 as crucial for Hsp104 hexamerization. Collectively, our findings unveil new facets of Hsp104 structure and mechanism. They also connect regions undergoing large changes in solvation to functionality, which could have profound implications for protein engineering.

摘要

Hsp104 是六聚体 AAA 环移位酶,它在非后生动物真核生物中驱动蛋白质解聚。Hsp104 的冷冻电镜结构提出了底物移位的潜在机制,但 Hsp104 六聚体如何解聚蛋白质仍不完全清楚。在这里,我们使用同步加速器 X 射线足迹法探测 Hsp104 单体在无核苷酸和 Hsp104 六聚体在 ADP 或 ATPγS(腺苷 5'--(硫代三磷酸))存在下的溶液状态结构。将这三种状态之间的侧链溶剂可及性进行比较,揭示了 Hsp104 结构的各个方面,并指导设计 Hsp104 变体以探测解聚酶机制。我们确定 Hsp104 六聚体从 ADP 中的更溶剂化状态转变为 ATPγS 中的较少溶剂化状态,这与冷冻电镜观察到的从开放螺旋到封闭环的转变一致。我们确定了关键的 N 端结构域(NTD)、NTD-核苷酸结合域 1(NBD1)接头、NBD1 和中间结构域(MD)残基,这些残基能够实现内在的解聚酶活性和 Hsp70 协作。我们发现了 A1 和 A2 螺旋之间环上的 NTD 残基,可以取代这些残基以增强解聚酶活性。我们阐明了一种新型增强的 Hsp104 MD 变体 Hsp104-RYD,它可以抑制 α-突触核蛋白、肉瘤融合蛋白(FUS)和 TDP-43 毒性。我们澄清了 NBD1 中的一个辅助孔环,它与 NTD 和 NBD1 酪氨酸孔环协作驱动蛋白质解聚。最后,我们确定 NBD2 中的 Leu-601 对 Hsp104 六聚体化至关重要。总的来说,我们的发现揭示了 Hsp104 结构和机制的新方面。它们还将经历溶剂化变化较大的区域与功能联系起来,这可能对蛋白质工程产生深远影响。